The Relative Strength Index reference data for Spero Therapeutics is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes. All values shown are derived from publicly available market data.
The forecast reference data presented here for Spero Therapeutics reflects Relative Strength Index model output and is intended as reference material for analytical use.
Relative Strength Index Analysis Today
Spero Therapeutics has current Relative Strength Index of 70.87.
On March 26 2026 Spero Therapeutics was traded for 2.37 at the closing time. The top price for the day was 2.48 and the lowest listed price was 2.34 . The trading volume for the day was 482.4 K. The trading history from March 26, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.84% .
Fibonacci retracement levels applied to Spero Stock price swings identify potential support and resistance zones. Extreme price moves in Spero occur more frequently than standard risk models assume. Support and resistance levels derived from Spero Therapeutics' historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move can signal accumulation or distribution ahead of a directional breakout.
The peer firms below within the Health Care space can help frame Spero Therapeutics' pricing and running costs in context. Checking cash flow across this peer set helps gauge Spero Therapeutics' relative financial strength. Peer pricing works best when the firms compared share similar business models and end markets. This peer set gives the context needed for a well-rounded view of Spero Therapeutics.
Tracking market strength indicators for Spero Therapeutics provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Spero Therapeutics is likely to be most rewarding. These tools are essential for timing trades in Spero Therapeutics with a quantitative framework. Market strength indicators for Spero Therapeutics are most useful when viewed as part of a broader analytical framework.
Properly assessing Spero Therapeutics' risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Spero Therapeutics'. Analyzing Spero Therapeutics' risk indicators provides a critical input for investment risk management. By quantifying the risk in Spero Therapeutics' investment, investors can make more informed decisions about hedging strategies.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Spero Therapeutics
A coverage review of Spero Therapeutics shows when the security is attracting above-average attention from contributors and market observers. A disciplined read of coverage separates durable relevance from temporary noise.
Short-interest signals around Spero Therapeutics can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding
54 M
Cash And Short Term Investments
52.9 M
More Resources for Spero Stock Analysis
A baseline understanding of Spero Therapeutics is formed through its financial statements and trends. Highlighted below are reports that provide context for Spero Therapeutics Stock:
